Red-cell 2,3-diphosphoglycerate in surgical correction of cyanotic congenital heart disease.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002245:Carbon Dioxide / Q000097:blood; D002648:Child; D002675:Child, Preschool; D004163:Diphosphoglyceric Acids / Q000097:blood; D004912:Erythrocytes / Q000032:analysis* / Q000187:drug effects; D004987:Ethers / Q000494:pharmacology; D005988:Glyceric Acids / Q000097:blood*; D006221:Halothane / Q000494:pharmacology; D006330:Heart Defects, Congenital / Q000097:blood* / Q000601:surgery; D006801:Humans; D006863:Hydrogen-Ion Concentration; D000860:Hypoxia / Q000097:blood / Q000628:therapy; D007223:Infant; D008875:Middle Aged; D009609:Nitrous Oxide / Q000494:pharmacology; D009943:Organophosphorus Compounds / Q000097:blood*; D010100:Oxygen / Q000097:blood
D004163:Diphosphoglyceric Acids; D004987:Ethers; D005988:Glyceric Acids; D009943:Organophosphorus Compounds; D002245:Carbon Dioxide; D009609:Nitrous Oxide; D010100:Oxygen; D006221:Halothane